The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

A.B. Katasonov

Mental Health Research Center

Dihydroquercetin as a systemic neuroprotector for the prevention and treatment of β-amyloid-associated brain diseases

Authors:

A.B. Katasonov

More about the authors

Views: 5686

Downloaded: 88


To cite this article:

Katasonov AB. Dihydroquercetin as a systemic neuroprotector for the prevention and treatment of β-amyloid-associated brain diseases. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;123(7):136‑142. (In Russ.)
https://doi.org/10.17116/jnevro2023123071136

Recommended articles:
Cere­brolysin in the treatment of cognitive impairment. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(3):20-25
Cognitive diso­rders in burnout syndrome. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(5):139-144
Modern possibilities of early diagnosis of Alzheimer’s disease in patients with primary open-angle glaucoma. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(6):121-128
B vita­mins and brain dysfunction. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(7):97-101
Obstructive sleep apnea — unde­restimated cognitive impairments risk factor. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2023;(8):36-41
Modern achievements in the diagnosis and treatment of glaucoma. Vestnik Ofta­lmologii. 2023;(3):96-106

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.